India's drug regulator has approved Takeda's Qdenga dengue vaccine, the first of its kind. This vaccine is expected to become available in India during the first half of 2027. Qdenga offers protection against all four dengue virus serotypes for individuals aged four to sixty. The vaccine demonstrated significant efficacy in late-stage trials, reducing cases and hospitalisations. Takeda is also partnering with Biological E to boost global manufacturing capacity for Qdenga.
RSS News
Economic times
0 thoughts on “Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in India”
Leave a Reply
Your email address will not be published. Required fields are marked *
RECENT NEWS
- PHC Mogla brings healthcare closer to Rajouri's remote villages
- Pedro Pascal talks about Reed Richards and Dr Doom’s connection
- David Jonsson welcomed by Winston Duke for 'Black Panther 3'
- DMK demands immediate NEET ban, seeks probe into Jantar Mantar violence
- Katrina set to make her comeback with 'Spirit'? Fact Check
